about
sameAs
Arsenic - Poison or medicine?Guidelines for dietary management of menopausal women with simple obesityObesity, adipose tissue function and the role of vitamin D.Single nucleotide polymorphisms for genes encoding cytokines in the context of cardiac surgery. Part I: Heart transplantationEffect of omeprazole on the concentration of interleukin-6 and transforming growth factor-β1 in patients receiving dual antiplatelet therapy after percutaneous coronary intervention.Serum interleukin-6 concentration predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.Plasma pentraxin 3 may be a more sensitive marker of inflammatory response than high-sensitivity C-reactive protein after bare-metal stent compared to drug-eluting stent implantation.Radiocontrast-induced thyroid dysfunction: is it common and what should we do about it?Prognostic impact of multimorbidity in patients with type 2 diabetes and ST-elevation myocardial infarction.Association between multimorbidity and mean platelet volume in diabetic patients with acute myocardial infarction.Platelet Volume Measurements-EDTA, Citrate, or Both?Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease.Pentraxin-3 and coronary artery disease.Primary sarcoma of the heart.Effects of trimetazidine on interleukin-2 and interleukin-8 concentrations in patients with coronary artery disease.Modulation of tumor necrosis factor-alpha (TNF-alpha) toxicity by the pineal hormone melatonin (MLT) in metastatic solid tumor patientsIs there a role for melatonin in the treatment of neoplastic cachexia?Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary interventionSerum interleukin-6 concentration reflects the extent of asymptomatic left ventricular dysfunction and predicts progression to heart failure in patients with stable coronary artery diseaseNo predictive value of serum interleukin-6 and transforming growth factor-beta1 in identifying patients with a first restenosis, recurrent restenosis or a history of restenosisAmiodarone-related thyroid dysfunctionPentraxin-3 concentrations in stable coronary artery disease depend on the clinical presentationAntithyroid drugs during breastfeedingThiol/disulfide homeostasis: A new insight into coronary artery ectasiaMultiple symmetric lipomatosisThe Association between Serum Levels of 25[OH]D, Body Weight Changes and Body Composition Indices in Patients with Heart Failure
P50
Q26752486-E2F5BB83-BB83-4450-92FE-2E4276333637Q26795576-88186623-DDB8-4518-B0BC-5CABCABB306AQ35631849-8E5DA9D0-3DF4-4BC1-A297-5CAE5C329789Q35903927-49DB354D-85ED-4A0B-979C-CA95DE0E383EQ42805811-230849F3-F37B-40A1-9555-636E1E9B207CQ43059688-DFC27C1A-1DCB-4486-BE92-9BB750D20842Q45791724-23D18E8F-37EE-4C26-B7EB-450E2092D342Q45998721-6A122C95-CB53-448E-8AB1-6917E519711AQ47103769-01EDAD6A-CCBE-4D6A-A7EF-9F2F87153301Q47391905-D998D24A-1872-45EB-A25C-F38A77F530C6Q48115808-97FD9D2C-45A2-4613-BBE1-7027D26A7B6AQ48293075-C8290720-C557-48E9-89DB-F9026A601A26Q49347538-59C5B7BE-497E-405B-B61D-478F9A774D7AQ50076909-FEB15F84-4190-4CD8-A24C-CA315D138348Q51122090-6F852E23-4746-49AD-8866-88A93BB22AA8Q70799128-A0155A6D-7924-4F44-82A5-5E273DD3D044Q71680931-998AE9DB-7F87-46C5-93B5-62C7EB077E47Q82718517-185B4FB4-F0B8-4386-8380-DDEB2B741FFEQ83555038-1D20836E-6F69-4BDB-9FAB-B84251978BC8Q84713746-630E74D0-5AEE-4013-9001-B58DFB70D0C7Q85877518-37494427-67C7-4FF3-BEA9-BE55302BBDE9Q85915375-061AF8B5-BB3E-409A-A6B2-5E6ED2FFCED4Q88203519-83559DD8-1E70-4169-A148-6D39D979F274Q88219652-EB6BC1E6-FD78-4039-A7BC-B0D5DC2C296DQ88456236-EACCB597-AD2A-42C9-9545-D10C22F8FC78Q94449398-D54CED1E-312D-44D5-B78D-958725310C88
P50
description
Polish endocrinologist
@en
Pools arts
@nl
inchríneolaí Polannach
@ga
polska lekarka, endokrynolog
@pl
name
Barbara Zubelewicz-Szkodzińska
@ast
Barbara Zubelewicz-Szkodzińska
@ca
Barbara Zubelewicz-Szkodzińska
@cs
Barbara Zubelewicz-Szkodzińska
@en
Barbara Zubelewicz-Szkodzińska
@es
Barbara Zubelewicz-Szkodzińska
@ga
Barbara Zubelewicz-Szkodzińska
@gl
Barbara Zubelewicz-Szkodzińska
@hr
Barbara Zubelewicz-Szkodzińska
@hsb
Barbara Zubelewicz-Szkodzińska
@it
type
label
Barbara Zubelewicz-Szkodzińska
@ast
Barbara Zubelewicz-Szkodzińska
@ca
Barbara Zubelewicz-Szkodzińska
@cs
Barbara Zubelewicz-Szkodzińska
@en
Barbara Zubelewicz-Szkodzińska
@es
Barbara Zubelewicz-Szkodzińska
@ga
Barbara Zubelewicz-Szkodzińska
@gl
Barbara Zubelewicz-Szkodzińska
@hr
Barbara Zubelewicz-Szkodzińska
@hsb
Barbara Zubelewicz-Szkodzińska
@it
altLabel
B Zubelewicz
@en
B Zubelewicz
@nl
Barbara Maria Zubelewicz
@en
Barbara Maria Zubelewicz
@pl
Barbara Maria Zubelewicz-Szkodzińska
@en
Barbara Maria Zubelewicz-Szkodzińska
@pl
Barbara Zubelewicz-Szkodzinska
@en
prefLabel
Barbara Zubelewicz-Szkodzińska
@ast
Barbara Zubelewicz-Szkodzińska
@ca
Barbara Zubelewicz-Szkodzińska
@cs
Barbara Zubelewicz-Szkodzińska
@en
Barbara Zubelewicz-Szkodzińska
@es
Barbara Zubelewicz-Szkodzińska
@ga
Barbara Zubelewicz-Szkodzińska
@gl
Barbara Zubelewicz-Szkodzińska
@hr
Barbara Zubelewicz-Szkodzińska
@hsb
Barbara Zubelewicz-Szkodzińska
@it
P214
P244
P101
P106
P1153
55963412400
P1412
P1559
Barbara Zubelewicz-Szkodzińska
@pl
P21
P213
0000 0000 4553 6029
P214
P244
no2001010127
P27
P31
P3124
P496
0000-0002-8670-8581
P569
1965-01-01T00:00:00Z
P7293
9810638330105606
P7859
lccn-no2001010127